These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 19035282)

  • 1. Molecular mechanisms and gene regulation of melphalan- and hyperthermia-induced apoptosis in Ewing sarcoma cells.
    Krause C; Klüttermann K; Mauz-Körholz C
    Anticancer Res; 2008; 28(5A):2585-93. PubMed ID: 19035282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRAIL-induced cytotoxicity in a melphalan-resistant rhabdomyosarcoma cell line via activation of caspase-2.
    Klüttermann K; Banning U; Kachel M; Krause C; Körholz D; Mauz-Körholz C
    Anticancer Res; 2006; 26(1A):351-6. PubMed ID: 16475717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of cellular FLICE inhibitory protein, caspase-8, and protease inhibitor-9 in Ewing sarcoma and implications for susceptibility to cytotoxic pathways.
    de Hooge AS; Berghuis D; Santos SJ; Mooiman E; Romeo S; Kummer JA; Egeler RM; van Tol MJ; Melief CJ; Hogendoorn PC; Lankester AC
    Clin Cancer Res; 2007 Jan; 13(1):206-14. PubMed ID: 17200356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitization of human Ewing's tumor cells to chemotherapy and heat treatment by the bioflavonoid quercetin.
    Debes A; Oerding M; Willers R; Göbel U; Wessalowski R
    Anticancer Res; 2003; 23(4):3359-66. PubMed ID: 12926076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-induced caspase-3 activation in a Ewing tumor cell line and primary Ewing tumor cells.
    Mauz-Körholz C; Kachel M; Harms-Schirra B; Klein-Vehne A; Tunn PU; Körholz D
    Anticancer Res; 2004; 24(1):145-9. PubMed ID: 15015589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanisms of hyperthermia- and cisplatin-induced cytotoxicity in T cell leukemia.
    Mauz-Körholz C; Dietzsch S; Schippel P; Banning U; Körholz D
    Anticancer Res; 2003; 23(3B):2643-7. PubMed ID: 12894552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of hyperthermia- and 4-hydroperoxy-ifosfamide-induced cytotoxicity in T cell leukemia.
    Mauz-Körholz C; Dietzsch S; Banning U; Tröbs RB; Körholz D
    Anticancer Res; 2002; 22(6C):4243-7. PubMed ID: 12553065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotypic and phenotypic comparisons of de novo and acquired melphalan resistance in an isogenic multiple myeloma cell line model.
    Hazlehurst LA; Enkemann SA; Beam CA; Argilagos RF; Painter J; Shain KH; Saporta S; Boulware D; Moscinski L; Alsina M; Dalton WS
    Cancer Res; 2003 Nov; 63(22):7900-6. PubMed ID: 14633719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic antitumor effect of melatonin with several chemotherapeutic drugs on human Ewing sarcoma cancer cells: potentiation of the extrinsic apoptotic pathway.
    Casado-Zapico S; Rodriguez-Blanco J; García-Santos G; Martín V; Sánchez-Sánchez AM; Antolín I; Rodriguez C
    J Pineal Res; 2010 Jan; 48(1):72-80. PubMed ID: 20025643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-Jun NH2-terminal kinase activation is essential for DRAM-dependent induction of autophagy and apoptosis in 2-methoxyestradiol-treated Ewing sarcoma cells.
    Lorin S; Borges A; Ribeiro Dos Santos L; Souquère S; Pierron G; Ryan KM; Codogno P; Djavaheri-Mergny M
    Cancer Res; 2009 Sep; 69(17):6924-31. PubMed ID: 19706754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The alkylating prodrug J1 can be activated by aminopeptidase N, leading to a possible target directed release of melphalan.
    Wickström M; Viktorsson K; Lundholm L; Aesoy R; Nygren H; Sooman L; Fryknäs M; Vogel LK; Lewensohn R; Larsson R; Gullbo J
    Biochem Pharmacol; 2010 May; 79(9):1281-90. PubMed ID: 20067771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the intrinsic apoptosis pathway downstream of caspase-9 activation causes chemotherapy resistance in diffuse large B-cell lymphoma.
    Cillessen SA; Hess CJ; Hooijberg E; Castricum KC; Kortman P; Denkers F; Vos W; van de Wiel MA; Schuurhuis GJ; Ossenkoppele GJ; Meijer CJ; Oudejans JJ
    Clin Cancer Res; 2007 Dec; 13(23):7012-21. PubMed ID: 18056177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing the factors which modify thermal enhancement of melphalan in a spontaneous murine tumor.
    Mohamed F; Stuart OA; Glehen O; Urano M; Sugarbaker PH
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):719-24. PubMed ID: 16614851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thermal enhancement of melphalan and oxaliplatin cytotoxicity in vitro.
    Urano M; Ling CC
    Int J Hyperthermia; 2002; 18(4):307-15. PubMed ID: 12079586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-gout agent allopurinol exerts cytotoxicity to human hormone-refractory prostate cancer cells in combination with tumor necrosis factor-related apoptosis-inducing ligand.
    Yasuda T; Yoshida T; Goda AE; Horinaka M; Yano K; Shiraishi T; Wakada M; Mizutani Y; Miki T; Sakai T
    Mol Cancer Res; 2008 Dec; 6(12):1852-60. PubMed ID: 19074830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trichostatin A sensitizes human ovarian cancer cells to TRAIL-induced apoptosis by down-regulation of c-FLIPL via inhibition of EGFR pathway.
    Park SJ; Kim MJ; Kim HB; Sohn HY; Bae JH; Kang CD; Kim SH
    Biochem Pharmacol; 2009 Apr; 77(8):1328-36. PubMed ID: 19426671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microarray analysis of Ewing's sarcoma family of tumours reveals characteristic gene expression signatures associated with metastasis and resistance to chemotherapy.
    Schaefer KL; Eisenacher M; Braun Y; Brachwitz K; Wai DH; Dirksen U; Lanvers-Kaminsky C; Juergens H; Herrero D; Stegmaier S; Koscielniak E; Eggert A; Nathrath M; Gosheger G; Schneider DT; Bury C; Diallo-Danebrock R; Ottaviano L; Gabbert HE; Poremba C
    Eur J Cancer; 2008 Mar; 44(5):699-709. PubMed ID: 18294840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of lexatumumab-induced apoptosis in human solid cancer cells by Cisplatin in caspase-dependent manner.
    Wu XX; Kakehi Y
    Clin Cancer Res; 2009 Mar; 15(6):2039-47. PubMed ID: 19276256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to melphalan in up-front investigational window therapy for patients with metastatic Ewing's family tumours.
    Luksch R; Grignani G; Fagioli F; Brach del Prever A; Podda M; Aliberti S; Casanova M; Prete A; Hanau G; Tamburini A; Allione P; Tienghi A; Ferrari S; Collini P; Marchianò A; Gandola L; Aglietta M; Madon E; Picci P; Fossati-Bellani F
    Eur J Cancer; 2007 Mar; 43(5):885-90. PubMed ID: 17254770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Over-expression of Reticulon 3 (RTN3) enhances TRAIL-mediated apoptosis via up-regulation of death receptor 5 (DR5) and down-regulation of c-FLIP.
    Lee JT; Lee TJ; Kim CH; Kim NS; Kwon TK
    Cancer Lett; 2009 Jul; 279(2):185-92. PubMed ID: 19250737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.